Anti-CRE Agents Are Used Less Widely Than Expected After FDA Approval - Infectious Disease Advisor
https://www.infectiousdiseaseadvisor.com/home/topics/emerging-diseases/antibiotics-antimicrobial-resistance/carbapenem-resistant-bacteria-still-commonly-treated-with-polymyxins/Clinicians Only Using New Antibiotics in Quarter of CRE Infection Cases, New Study Finds
https://www.contagionlive.com/news/clinicians-only-using-new-antibiotics-in-quarter-of-cre-infection-cases-new-study-findsEstimating the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in the United States Using Antibiotic Prescription Data | Open Forum Infectious Diseases | Oxford Academic
https://academic.oup.com/ofid/article/6/8/ofz344/5539997Physicians Slow to Use Effective New Antibiotics Against Superbugs
https://scitechdaily.com/physicians-slow-to-use-effective-new-antibiotics-against-superbugs/Physicians Slow to Use New Antibiotics Against Superbugs
https://www.upmc.com/media/news/082619-clancy-cre-new-drugsPhysicians slow to use effective new antibiotics against superbugs -- ScienceDaily
https://www.sciencedaily.com/releases/2019/08/190826092307.htmSlow Uptake Among Physicians of Effective Antibiotics to Treat Superbugs
https://www.ajmc.com/focus-of-the-week/slow-uptake-among-physicians-of-effective-antibiotics-to-treat-superbugsU.S. spending to combat dangerous superbugs is too low, experts say
https://www.consumeraffairs.com/news/us-spending-to-combat-dangerous-superbugs-is-too-low-experts-say-100919.html